The DOI matches its Crossref record.
Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
Abstract
In this report, the modulation and localization of complement receptors CR1 and CR3 in neutrophils were examined with the use of monoclonal antibodies (mab) directed against these membrane proteins. We first studied complement receptor modulation in a patient with neutrophil-specific granule deficiency. With flow cytometric analysis, we determined that, while N-formyl-methionyl-leucyl-phenylalanine (f-met-leu-phe) (10(-6) M) caused an increase in the binding of both anti-CR1 and anti-CR3 mab to normal neutrophils, the fmet-leu-phe-stimulated neutrophils from our patient increased anti-CR1 binding but decreased anti-CR3 binding. This suggested that CR3, but not CR1, might be associated with specific granules. We next studied receptor modulation in organelle-depleted neutrophil cytoplasts obtained from normal donors. Unlike the specific granule-deficient neutrophils, the normal cytoplasts failed to augment expression of either receptor after stimulation. Immunofluorescence studies of permeabilized polymorphonuclear leukocytes (PMN) revealed considerable internal binding of both anti-CR1 and anti-CR3. In additional studies, phorbol myristate acetate (PMA) was used as a stimulus for receptor modulation in normal neutrophils. Unlike fmet-leu-phe and C5a, PMA elicited a biphasic dose-response curve. High doses of PMA (greater than 0.5 ng/ml) caused a reduction in the magnitude of membrane expression of both CR1 and CR3. In studies designed to localize the internal pool of receptors, we evaluated the binding of 125I-anti-receptor mab to plasma membrane-, specific granule, and azurophilic granule-enriched fractions obtained from sucrose gradient fractionation of disrupted neutrophils. 125I-anti-CR1 mab bound to the membrane-enriched fraction but bound little to either granule-enriched fraction. In contrast, 125I-anti-CR3 mab bound more to the specific granule-enriched fraction than to the plasma membrane-enriched fraction. Azurophilic granules showed no increased anti-CR3 binding. Immunoprecipitation of radiolabeled solubilized subcellular fractions with anti-receptor mab confirmed these findings. CR3 was present in the plasma membrane-, and specific granule-enriched fraction but not in the azurophilic granule-enriched fraction. CR1, however, was present only in the plasma membrane-enriched fraction. These data indicate that there are intracellular pools for both the CR1 and CR3, but the intracellular locations for these pools are distinct. The pool for CR3 co-sediments with specific granules, while the pool for CR1 does not. Nonetheless, a variety of stimulatory agents increase and decrease the membrane expression of both receptors in parallel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Smith, C. W., Marlin, S. D., Rothlein, R., Toman, C., & Anderson, D. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114111 · Cited by 1,092
Structure and function of the leukocyte adhesion molecules CD11/CD18
Arnaout, M. (1990) · Blood · doi:10.1182/blood.v75.5.1037.1037 · Cited by 1,035
Malech, H. L., & Gallin, J. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171107 · Cited by 838
Self-citationThe role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 503
Self-citationKuijpers, T., Tool, A., van der Schoot, C., Ginsel, L., Onderwater, J., Roos, D., & Verhoeven, A. (1991) · Blood · doi:10.1182/blood.v78.4.1105.1105 · Cited by 452
Follicular Dendritic Cells Carry MHC Class II-Expressing Microvesicles at Their Surface
Denzer, K., van Eijk, M., Kleijmeer, M. J., Jakobson, E., de Groot, C., & J. Geuze, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1259 · Cited by 451
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)
Ahearn, J. M., & Fearon, D. T. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60654-9 · Cited by 448
The Regulators of Complement Activation (RCA) Gene Cluster
Hourcade, D., Holers, V. M., & Atkinson, J. P. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439
Brown, E., Hooper, L., Ho, T., & Gresham, H. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.2785 · Cited by 407
Self-citationLehrer, R. I., Ganz, T., Selsted, M. E., Babior, B. M., & Curnutte, J. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-2-127 · Cited by 372
Vedder, N. B., & Harlan, J. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113372 · Cited by 330
Moser, R., Schleiffenbaum, B., Groscurth, P., & Fehr, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113903 · Cited by 320
Zhou, M. J., & Brown, E. J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1407 · Cited by 319
Self-citationArnaout, M. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00564.x · Cited by 303
Wright, S. D., Ramos, R. A., Hermanowski-Vosatka, A., Rockwell, P., & Detmers, P. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1281 · Cited by 285
Bullock, W. E., & Wright, S. D. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.195 · Cited by 260
Ectosomes Released by Human Neutrophils Are Specialized Functional Units
Hess, C., Sadallah, S., Hefti, A., Landmann, R., & Schifferli, J.-A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4564 · Cited by 258
Brown, E. J., & Goodwin, J. L. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.777 · Cited by 163
Self-citation
Metadata
- Authors
- O’Shea, J. J., Brown, E. J., Seligmann, B. E., Metcalf, J. A., Frank, M. M., & Gallin, J. I.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-04-01
- Volume
- 134
- Issue
- 4
- Pages
- 2580-2587
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1569662926
- Cited by
- 284
- References
- 0
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.